Is Monopar Therapeutics Inc. (MNPR) a Buy, Sell, or Hold?
Monopar Therapeutics Inc.
NASDAQ:MNPR
$99.79 USD
-$3.54 (-3.43%)
- Volume
- 498.25K
- Average Volume
- 172.64K
- Market Capitalization
- $668.5M
- P/E Ratio
- -48.21
- Dividend Yield
- 0.00%
- Price Target
- $105.00
- Year High
- $112.57
- Year Low
- $29.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $56.04
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-5.0% DOWNSIDE
$105.00 Price Target
UPSIDE/DOWNSIDE HIGH
-14.7% DOWNSIDE
$117.00 Price Target High
UPSIDE/DOWNSIDE LOW
-5.0% DOWNSIDE
$105.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Maxwell Skor | $115 | $63.4 | 2026-01-09 05:11 AM | 81.4% |
| Raymond James | Chris Raymond | $123 | $87.01 | 2025-11-14 05:06 AM | 41.4% |
| Barclays | Etzer Darout | $125 | $87.82 | 2025-10-13 05:25 AM | 42.3% |
| Chardan Capital | Keay Nakae | $85 | $72.695 | 2025-09-25 07:55 AM | 16.9% |